n.a. (BRLI)

34.61
0.34 0.97
NASDAQ
Prev Close 34.95
Open 34.74
Day Low/High 34.03 / 34.96
52 Wk Low/High /
Volume 423.74K
Exchange NASDAQ
Div & Yield N.A. (N.A)
BioReference Laboratories, Inc. Launches OnkoSight(TM), An Advanced Tumor Sequencing Program

BioReference Laboratories, Inc. Launches OnkoSight(TM), An Advanced Tumor Sequencing Program

NextGen Sequencing Expert Leads Company Initiative With Custom, Cost Effective Panels in Both Solid Tumors and Hematologic Cancers

BioReference Laboratories, Inc. Hires Industry Veteran, Joseph F. Donahue, To Lead New Business Group

BioReference Laboratories, Inc. Hires Industry Veteran, Joseph F. Donahue, To Lead New Business Group

The New Business Group Will be the Commercial Collaborations and Innovations Group

BioReference Laboratories, Inc. Announces Quarterly And Yearly Record Revenues, Net Income And Patient Volumes

BioReference Laboratories, Inc. Announces Quarterly And Yearly Record Revenues, Net Income And Patient Volumes

The Company's Fourth Quarter Financial Results Showed Substantial Year Over Year Improvement

5 Earnings Short-Squeeze Plays: BlackBerry, Pier 1 and More

5 Earnings Short-Squeeze Plays: BlackBerry, Pier 1 and More

You only need to find a few of these stocks in a year to juice your portfolio returns.

Bio-Reference Laboratories (BRLI) Shares Cross Above 200 DMA

Bio-Reference Laboratories (BRLI) Shares Cross Above 200 DMA

In trading on Monday, shares of Bio-Reference Laboratories, Inc. crossed above their 200 day moving average of $28.61, changing hands as high as $28.98 per share.

Generous 'Income' in a ZIRP World

Generous 'Income' in a ZIRP World

Low interest rates make prudent option selling attractive.

Bio-Reference Laboratories Breaks Below 200-Day Moving Average - Notable for BRLI

Bio-Reference Laboratories Breaks Below 200-Day Moving Average - Notable for BRLI

In trading on Tuesday, shares of Bio-Reference Laboratories, Inc. crossed below their 200 day moving average of $28.46, changing hands as low as $28.30 per share.

Book Gains and Reduce Risk

Book Gains and Reduce Risk

Option writers book profits while getting paid to try again.

RSI Alert: Bio-Reference Laboratories Now Oversold

RSI Alert: Bio-Reference Laboratories Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Get Some Positive Lab Results

Get Some Positive Lab Results

Try this options play for the sometimes volatile Bio-Reference Laboratories.

Williams-Sonoma Stumbles After Yesterday's Surge

Williams-Sonoma Stumbles After Yesterday's Surge

Repros Therapeutics Inc (NASDAQ:RPRX), Aquinox Pharmaceuticals Inc (NASDAQ:AQXP) and Signet Jewelers Ltd. (NYSE:SIG) are today's top-gaining billionaire stock picks midday. The losers are Williams-...

BioReference Laboratories, Inc. Reports Record Quarterly Revenues And Patient Volumes For Third Quarter FY2014

BioReference Laboratories, Inc. Reports Record Quarterly Revenues And Patient Volumes For Third Quarter FY2014

Revenues Increase 20% on a YoY Basis and Patient Count Increases 16%

5 Hated Earnings Stocks You Should Love

5 Hated Earnings Stocks You Should Love

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

More Sideways Action

Amid today's narrow trading was ongoing uncertainty about events in the Middle East.

Bio-Reference Laboratories Stock Sees Short Interest Decline 10.6%

Bio-Reference Laboratories Stock Sees Short Interest Decline 10.6%

The most recent short interest data has been released by the NASDAQ for the 05/30/2014 settlement date, which shows a 849,564 share decrease in total short interest for Bio-Reference Laboratories, Inc. , to 7,204,298, a decrease of 10.55% since 05/15/2014.

Perilous Reversal Watch: Bio-Reference Laboratories (BRLI)

Perilous Reversal Watch: Bio-Reference Laboratories (BRLI)

Trade-Ideas LLC identified Bio-Reference Laboratories (BRLI) as a "perilous reversal" (up big yesterday but down big today) candidate

Ratings Changes Today

Upgrades: ABR, ALN, ASBI, BRLI, HK, NSEC, PCL, QLYS, SMTP Downgrades: AIRI, BSPM, BVX, CNTY, EC, MCEP, OIS, VCO, VRA Initiations: RALY Read on to get TheStreet Quant Ratings' detailed report:

Why Bio-Reference Labs (BRLI) Stock Is Surging Today

Why Bio-Reference Labs (BRLI) Stock Is Surging Today

Bio-Reference Labs (BRLI) surged Thursday after the company reported second-quarter earnings that surpassed analysts' expectations.

Bio-Reference Laboratories (BRLI) Shares Cross Above 200 DMA

Bio-Reference Laboratories (BRLI) Shares Cross Above 200 DMA

In trading on Thursday, shares of Bio-Reference Laboratories, Inc. crossed above their 200 day moving average of $28.15, changing hands as high as $30.72 per share.

BioReference Laboratories, Inc. Reports Record Quarterly Revenues And Patient Volumes For Second Quarter FY2014

BioReference Laboratories, Inc. Reports Record Quarterly Revenues And Patient Volumes For Second Quarter FY2014

Quarterly Revenues and Patient Volumes Both Increased by Over 14%, Cash Flow Returned to Positive

5 Stocks Set to Soar on Bullish Earnings

5 Stocks Set to Soar on Bullish Earnings

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

Bio-Reference Laboratories, Inc. Announces That Robert Daber, Ph.D. Will Join Company As Director Of R&D And Cancer Genetics

Bio-Reference Laboratories, Inc. Announces That Robert Daber, Ph.D. Will Join Company As Director Of R&D And Cancer Genetics

Former University of Pennsylvania Technical Director of Clinical Genetics Will Lead BRLI Cancer Genetics Program

The Art of the Put-Option Sale

The Art of the Put-Option Sale

If you understand options and have patience and money, this method offers a healthy margin of safety.

Interesting BRLI Put And Call Options For June 21st

Interesting BRLI Put And Call Options For June 21st

Investors in Bio-Reference Laboratories, Inc. saw new options begin trading today, for the June 21st expiration.

3 Stocks Rising on Unusual Volume

3 Stocks Rising on Unusual Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

BRLI Crosses Above Key Moving Average Level

BRLI Crosses Above Key Moving Average Level

In trading on Wednesday, shares of Bio-Reference Laboratories, Inc. crossed above their 200 day moving average of $28.33, changing hands as high as $28.85 per share.

Bio-Reference Laboratories, Inc. Reports Revenue Growth Despite Reimbursement Pressure And Impactful Weather

Bio-Reference Laboratories, Inc. Reports Revenue Growth Despite Reimbursement Pressure And Impactful Weather

Q1FY14 Results Continue to Show the Effects of Reimbursement Pressures